ArticleFrontiers in pharmacology2024

A real-world pharmacovigilance analysis of eslicarbazepine acetate using the FDA adverse events reporting system (FAERS) database from 2013 (Q4) to 2024 (Q1).

Huafei Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.